000 01489 a2200457 4500
005 20250516041547.0
264 0 _c20120426
008 201204s 0 0 eng d
022 _a1434-9949
024 7 _a10.1007/s10067-011-1758-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSathi, Navtej
245 0 0 _aHow common is methotrexate pneumonitis? A large prospective study investigates.
_h[electronic resource]
260 _bClinical rheumatology
_cJan 2012
300 _a79-83 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCardiovascular Diseases
_xepidemiology
650 0 4 _aComorbidity
650 0 4 _aConnective Tissue Diseases
_xepidemiology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMethotrexate
_xadverse effects
650 0 4 _aMiddle Aged
650 0 4 _aPneumonia
_xdiagnosis
650 0 4 _aProspective Studies
650 0 4 _aRespiratory Function Tests
650 0 4 _aUnited Kingdom
_xepidemiology
650 0 4 _aYoung Adult
700 1 _aChikura, Batsirai
700 1 _aKaushik, Viswanath V
700 1 _aWiswell, Rose
700 1 _aDawson, Julie K
773 0 _tClinical rheumatology
_gvol. 31
_gno. 1
_gp. 79-83
856 4 0 _uhttps://doi.org/10.1007/s10067-011-1758-6
_zAvailable from publisher's website
999 _c20896440
_d20896440